JPMorgan
http://www.jpmorgan.comJPMorgan Chase & Co. (NYSE: JPM) is a leading global financial services firm with assets of $1.5 trillion and operations in more than 50 countries. The firm is a leader in investment banking, financial services for consumers, small business and commercial banking, financial transaction processing, asset management, and private equity.
-
-
-
-
-
-
-
JPMorgan Reiterates Overweight Rating on BioCryst Pharma (BCRX)
-
-
-
-
-
-
-
BioCryst to Present at 42nd Annual J.P. Morgan Healthcare Conference
-
-
-
-
-
-
-
BioCryst Pharma (BCRX) Commences Public Offering of Common Stock and Pre-Funded Warrants
-
-
-
-
-
-
-
BioCryst Pharma (BCRX) Commences Public Offering of Common Stock and Pre-Funded Warrants
-
-
-
-
-
-
-
BioCryst Prices Public Offering of Common Stock
-
-
-
-
-
-
-
BioCryst Pharma (BCRX) Prices 9.09M Shares Common Offering at $5.50/Sh
-
-
-
-
-
-
-
BioCryst Pharmaceuticals (BCRX) and Idera Pharmaceuticals (IDRA) Announce Merger
-
291,876 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

